Literature DB >> 15072123

Trends in leprosy case detection worldwide since 1985.

Abraham Meima1, Jan H Richardus, J Dik F Habbema.   

Abstract

Trends in case detection and case detection rate (CDR) since 1985 are described at regional and national levels. Annual case detection by WHO Region was available for 1994-2000. Using different sources, complete time series for case detection were constructed for 1985-1998 for a group of 33 endemic countries cumulatively (top 33), and for 14 individual countries (top 14). Population statistics were used to derive CDRs. India contributed 79% to global case detection in 1998. Africa, the Americas and South-East Asia each contributed about 30% when India is excluded. During 1994-2000, case detection did not decrease in these three WHO Regions. The 33 countries contributed 99% and 98% to global case detection in 1994 and 1998, respectively. Cumulative case detection for the top 33 minus India gradually increased, overall almost doubling. The contribution of the top 14 to case detection of the top 33 hardly changed over time, equalling 96% in 1998 (81% when India is excluded). In terms of annual case detection, Brazil was always ranked second after India; it accounted for 27% of 1998 case detection in the top 33 except India. In 1998, seven of the top 14 countries--including India and Brazil--had CDRs above 2 per 10,000. The CDR did not exceed 1 per 10,000 for the other half. Decreasing tendencies in CDR, either for the whole period or in the 1990s, are observed for four of the top 14 countries (Guinea and three Western Pacific countries: China, Vietnam and the Philippines). In conclusion, there is no general decline in case detection to date, and several important countries still have high CDRs. Prevalence is an irrelevant indicator for monitoring epidemiological changes in leprosy. Trends in the transmission and incidence of leprosy are still completely unclear, necessitating further research. The target to eliminate leprosy as a public health problem, defined as a prevalence of less than 1 per 10,000, is therefore also an inadequate yardstick for decision making on leprosy control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072123

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  15 in total

1.  Leprosy: what is being "eliminated"?

Authors:  Paul E M Fine
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

2.  Leprosy Elimination: Progress and Challenges in Nigeria; Kaduna State TB and Leprosy Control Programme as a Case Study.

Authors:  Gidado Mustapha; Obasanya Joshua Olusegu; Sani Mustapha; Adesigbin Clement; Tahir Dahiru; J Gagere; Adejumo Adeleji Olusola
Journal:  Afr J Infect Dis       Date:  2012

Review 3.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

4.  Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers.

Authors:  M S Duthie; M N Hay; E M Rada; J Convit; L Ito; L K M Oyafuso; M I P Manini; I M B Goulart; J Lobato; L R Goulart; D Carter; S G Reed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

5.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

6.  Oro-facial manifestations of 100 leprosy patients.

Authors:  Jamileh-Bigom Taheri; Hamed Mortazavi; Mahkameh Moshfeghi; Mahin Bakhshi; Sedigheh Bakhtiari; Saranaz Azari-Marhabi; Somayeh Alirezaei
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

7.  Leprosy therapy, past and present: can we hope to eliminate it?

Authors:  P V S Prasad; P K Kaviarasan
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

8.  Leprosy--evolution of the path to eradication.

Authors:  Sunil Dogra; Tarun Narang; Bhushan Kumar
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

9.  Disability adjusted working life years (DAWLYs) of leprosy affected persons in India.

Authors:  P S S Rao; F Darlong; M Timothy; Sandeep Kumar; S Abraham; Royce Kurian
Journal:  Indian J Med Res       Date:  2013-05       Impact factor: 2.375

10.  Use of short tandem repeat sequences to study Mycobacterium leprae in leprosy patients in Malawi and India.

Authors:  Saroj K Young; Jorg M Ponnighaus; Suman Jain; Sebastian Lucas; Sujai Suneetha; Diana N J Lockwood; Douglas B Young; Paul E M Fine
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.